Skip to main
KIDS

OrthoPediatrics (KIDS) Stock Forecast & Price Target

OrthoPediatrics (KIDS) Analyst Ratings

Based on 9 analyst ratings
Strong Buy
Strong Buy 67%
Buy 22%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

OrthoPediatrics is well-positioned for long-term growth and profitability, as shown by their robust pipeline of innovative products still in development, and their successful track record of taking market share from larger competitors. Additionally, the company's exclusive focus on pediatric orthopedics and global distribution in over 70 countries outside the US solidifies their position as a leading player in this niche market. Moreover, strong distributor sentiment and surgeon demand for KIDS' Super Cycle products bode well for potential upside in revenue and operating leverage in the coming years.

Bears say

OrthoPediatrics is a medical device company that specializes in products for the pediatric orthopedic market, including implants and instruments. However, their focus on the pediatric market leaves them vulnerable to competition from larger players in the orthopedic industry. Additionally, the company's stocks are trading at depressed levels despite a solid growth rate. Risks to the stock include competition, slow product pipeline, and lack of intellectual property.

OrthoPediatrics (KIDS) has been analyzed by 9 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 22% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of OrthoPediatrics and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About OrthoPediatrics (KIDS) Forecast

Analysts have given OrthoPediatrics (KIDS) a Strong Buy based on their latest research and market trends.

According to 9 analysts, OrthoPediatrics (KIDS) has a Strong Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

OrthoPediatrics (KIDS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.